METHODS FOR DETERMINING DRUG EFFICACY USING IKZF3 (AIOLOS)
Provided herein is use of cereblon-associated protein IKZF3 (Aiolos) as a biomarker to indicate the efficacy of a compound to alter immune response in a subject, and to assess the efficacy of a compound in treating a cancer or an inflammatory disease.
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Provided herein is use of cereblon-associated protein IKZF3 (Aiolos) as a biomarker to indicate the efficacy of a compound to alter immune response in a subject, and to assess the efficacy of a compound in treating a cancer or an inflammatory disease. |
---|